Selective PPARA agonist GEMFIBROZIL may exert a protective role in IRI-AKI by reducing podocyte apoptosis (38); Celecoxib beneficially affects the outcome of renal IRI by reducing oxidative stress through decreasing COX-2 expression (39). This evidence concerns the gene PPARA and acute kidney injury.